Celgene pursues patent infringement litigation against KV Pharmaceutical concerning Ritalin LA®

September 2007

Jones Day represents Celgene Corporation in a Hatch-Waxman patent infringement case concerning a generic version of branded drug Ritalin LA®.

Celgene Corporation et al. v. KV Pharmaceutical Co. (D. N.J. 2007)

For additional information about this matter, please contact: Anthony M. Insogna, Lester J. Savit, Jason G. Winchester

Client(s): Celgene Corporation
Office(s): Chicago, San Diego